PTI: Aurobindo Pharma on Monday said it has completed the Euro 74-million deal to acquire Apotex’s operations in European countries
Aurobindo PharmaNSE 0.26 % Monday said it has completed the EUR 74-million deal to acquire Apotex’s commercial operations and certain supporting infrastructure in five European countries.
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex’ European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.
This announcement does not constitute a recommendation to shareholders or potential investors, it added.
Aurobindo Pharma shares were trading 0.94 per cent down at Rs 753.50 apiece on the BSE.
⇓Subscribe with your email to get new updates[jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]